Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,182.00    0.00 (0.00%)
Bid:
1,170.00
Ask:
1,200.00
Spread: 30.00 (2.564%)
Market Cap: £541.66m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Result of AGM

15 Sep 2020 15:39

RNS Number : 0800Z
Cohort PLC
15 September 2020
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

15 September

 

 

 

COHORT PLC

("Cohort" or "the Group")

Result of AGM

 

 

Cohort, the AIM listed independent technology group, announces that at its Annual General Meeting held earlier today all the resolutions contained within the Notice of Meeting dated 12 August 2020 were duly passed by shareholders.

 

A summary of the votes received for each resolution is as follows:

 

For1

% For

Against

% Against

Total

% Total2

Withheld3

Ordinary Resolutions

1: Accounts

19,459,540

62.61

11,622,016

37.39

31,081,556

75.86

1,213,195

2: Dividend

32,294,447

99.99

304

0.01

32,294,751

78.85

0

3: Re-elect Simon Walther

32,292,319

99.99

2,104

0.01

32,294,423

78.85

328

4: Re-elect Jeff Perrin

31,891,618

99.99

2,104

0.01

31,893,722

77.87

401,029

5: Appointment of Auditor

31,887,918

99.98

5,804

0.02

31,893,722

77.87

401,029

6: Auditor's Remuneration

32,292,619

99.99

1,804

0.01

32,294,423

78.85

328

7: Allot shares

31,885,715

99.98

7,885

0.02

31,893,600

77.87

401,151

Special Resolutions

8: Allot shares for cash

31,883,693

99.97

9,907

0.03

31,893,600

77.87

401,151

9: Disapply pre-emption rights

32,287,506

99.98

7,123

0.02

32,294,629

78.85

122

10: Purchase own shares

32,290,178

99.99

3,123

0.01

32,293,301

78.84

1,450

11: General meeting notice

38,287,388

99.98

7,363

0.02

38,294,751

93.50

0

 

Notes:

1. Any proxy appointments which gave discretion to the Chairman have been included in the "for" total.

2. The total number of shares in issue is 40,959,101.

3. A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a resolution.

4. All percentages are shown to two decimal places.

 

The Board of Cohort notes the 37% of votes cast against Resolution 1. None of the shareholders who voted against the resolution had communicated any concerns to the Company prior to casting their votes. Subsequent contact has indicated that the votes reflected concerns about aspects of the Group's governance and remuneration policy. The votes were cast against Resolution 1 in the absence of resolutions pertaining to the matters of concern. The Board will engage with shareholders to gain a better understanding of their concerns on these matters and decide on any appropriate responses. There have been no concerns expressed by shareholders to the Company regarding the accounts presented under Resolution 1 or the audit procedures.

 

Ends

 

For further information, please contact:

 

Cohort plc

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director and Company Secretary

Investec Bank plc

020 7597 5970

Daniel Adams / Chris Baird

MHP Communications

020 3128 8100

Reg Hoare / Pete Lambie

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of five innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Chess Technologies, through its operating businesses Chess Dynamics and Vision4ce, offers electro-optical and electro-mechanical systems to the defence and security markets. It was acquired by Cohort plc in December 2018. www.chess-dynamics.com & www.vision4ce.com

 

EID designs and manufactures advanced communications systems for the defence and security markets. Cohort acquired a majority stake in June 2016. www.eid.pt

 

MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

MCL designs, sources and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

SEA delivers products and services into the defence and transport markets alongside performing specialist research, training and product support. Acquired by Cohort in October 2007. www.sea.co.uk

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total around 900 core staff there and at its other operating company sites across the UK and in Portugal.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFIFLIESSEDU
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.